The cancer ‐related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma

ConclusionsThese results suggest that a combined Runx2/OPN expression could be a valuable independent predictor of tumor metastasis and survival in osteosarcoma patients.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research